ATE479428T1 - Olanzapin enthaltende pharmazeutische zusammensetzung - Google Patents

Olanzapin enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE479428T1
ATE479428T1 AT06831860T AT06831860T ATE479428T1 AT E479428 T1 ATE479428 T1 AT E479428T1 AT 06831860 T AT06831860 T AT 06831860T AT 06831860 T AT06831860 T AT 06831860T AT E479428 T1 ATE479428 T1 AT E479428T1
Authority
AT
Austria
Prior art keywords
olnzapine
pharmaceutical composition
composition containing
olanzapine
composition
Prior art date
Application number
AT06831860T
Other languages
English (en)
Inventor
Torfi Kristjansson
Original Assignee
Actavis Group Ptc Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35516297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE479428(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actavis Group Ptc Ehf filed Critical Actavis Group Ptc Ehf
Application granted granted Critical
Publication of ATE479428T1 publication Critical patent/ATE479428T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
AT06831860T 2005-11-03 2006-10-27 Olanzapin enthaltende pharmazeutische zusammensetzung ATE479428T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0522474.6A GB0522474D0 (en) 2005-11-03 2005-11-03 A pharmaceutical formulation
PCT/IB2006/003922 WO2007052164A2 (en) 2005-11-03 2006-10-27 A pharmaceutical formulation containing olanzapine

Publications (1)

Publication Number Publication Date
ATE479428T1 true ATE479428T1 (de) 2010-09-15

Family

ID=35516297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06831860T ATE479428T1 (de) 2005-11-03 2006-10-27 Olanzapin enthaltende pharmazeutische zusammensetzung

Country Status (8)

Country Link
EP (1) EP1928428B1 (de)
CN (1) CN101309673A (de)
AT (1) ATE479428T1 (de)
CA (1) CA2626585A1 (de)
DE (1) DE602006016621D1 (de)
ES (1) ES2350121T3 (de)
GB (1) GB0522474D0 (de)
WO (1) WO2007052164A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
CN104208031B (zh) * 2013-07-01 2016-08-31 成都苑东生物制药股份有限公司 一种奥氮平片组合物及其制备方法
ES2717715T3 (es) 2014-02-14 2019-06-24 Synthon Bv Composición farmacéutica que comprende polimorfo IV de clorhidrato de ivabradina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
SI21303A (sl) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Farmacevtska formulacija olanzapina
WO2004058223A1 (en) * 2002-12-20 2004-07-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
WO2005009407A2 (en) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Oral pharmaceutical formulations of olanzapine

Also Published As

Publication number Publication date
WO2007052164A8 (en) 2008-04-17
CA2626585A1 (en) 2007-05-10
DE602006016621D1 (de) 2010-10-14
GB0522474D0 (en) 2005-12-14
WO2007052164A3 (en) 2007-08-09
EP1928428B1 (de) 2010-09-01
ES2350121T3 (es) 2011-01-18
WO2007052164A2 (en) 2007-05-10
EP1928428A2 (de) 2008-06-11
CN101309673A (zh) 2008-11-19

Similar Documents

Publication Publication Date Title
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
EA201001083A1 (ru) Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
AR062000A1 (es) Formulaciones de modificador de respuesta inmune
CR8102A (es) Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
BRPI0719395C1 (pt) tablete revestido de filme
ATE337793T1 (de) Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
BRPI0507654A (pt) composição farmacêutica compreendendo um derivado de benzodiazepina e um inibidor da proteìna de fusão de rsv
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
CL2007003444A1 (es) Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
ATE415949T1 (de) Pharmazeutische formulierung mit levothyroxin- natrium
IS2677B (is) Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðu hjúpaða með sýrufjölliðu
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
NO20073023L (no) Forhindring av vertikal endoparasitt infeksjoner
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties